0 0 1 0 1 B-lower_bound
- 1 2 1 2 O
1 2 3 2 3 B-upper_bound
+ 3 4 3 4 O
HER2 5 9 5 9 B-cancer
expression 10 20 10 20 O
by 21 23 21 23 O
immunohistochemistry 24 44 24 44 B-treatment
( 45 46 45 46 I-treatment
IHC 46 49 46 49 I-treatment
) 49 50 49 50 I-treatment

Dilated 0 7 51 58 B-chronic_disease
cardiomyopathy 8 22 59 73 I-chronic_disease

Fluorescence 0 12 74 86 B-treatment
in 13 15 87 89 I-treatment
situ 16 20 90 94 I-treatment
hybridization 21 34 95 108 I-treatment
( 35 36 109 110 I-treatment
FISH 36 40 110 114 I-treatment
) 40 41 114 115 I-treatment
negative 42 50 116 124 O

Glycosylated 0 12 125 137 B-clinical_variable
hemoglobin 13 23 138 148 I-clinical_variable
measurement 24 35 149 160 I-clinical_variable
( 36 37 161 162 I-clinical_variable
HbA1c 37 42 162 167 I-clinical_variable
) 42 43 167 168 I-clinical_variable
< 44 45 169 170 O
5.7 46 49 171 174 B-upper_bound
% 49 50 174 175 I-upper_bound

Hemoglobin 0 10 176 186 B-clinical_variable
( 11 12 187 188 I-clinical_variable
Hgb 12 15 188 191 I-clinical_variable
) 15 16 191 192 I-clinical_variable
> 17 18 193 194 O
= 18 19 194 195 O
10 20 22 196 198 B-lower_bound
g 23 24 199 200 I-lower_bound
/ 24 25 200 201 I-lower_bound
dl 25 27 201 203 I-lower_bound

History 0 7 204 211 O
of 8 10 212 214 O
allergic 11 19 215 223 O
reactions 20 29 224 233 O
attributed 30 40 234 244 O
to 41 43 245 247 O
compounds 44 53 248 257 O
of 54 56 258 260 O
similar 57 64 261 268 O
chemical 65 73 269 277 O
or 74 76 278 280 O
biologic 77 85 281 289 O
composition 86 97 290 301 O
to 98 100 302 304 O
WOKVAC 101 107 305 311 B-allergy_name

History 0 7 312 319 O
of 8 10 320 322 O
autoimmunity 11 23 323 335 O
that 24 28 336 340 O
has 29 32 341 344 O
not 33 36 345 348 O
been 37 41 349 353 O
controlled 42 52 354 364 O
with 53 57 365 369 O
treatment 58 67 370 379 B-treatment
in 68 70 380 382 O
the 71 74 383 386 O
last 75 79 387 391 B-upper_bound
12 80 82 392 394 I-upper_bound
months 83 89 395 401 I-upper_bound

Known 0 5 402 407 O
history 6 13 408 415 O
of 14 16 416 418 O
human 17 22 419 424 B-chronic_disease
immunodeficiency 23 39 425 441 I-chronic_disease
virus 40 45 442 447 I-chronic_disease
( 46 47 448 449 I-chronic_disease
HIV 47 50 449 452 I-chronic_disease
) 50 51 452 453 I-chronic_disease
infection 52 61 454 463 I-chronic_disease

Left 0 4 464 468 B-clinical_variable
ventricular 5 16 469 480 I-clinical_variable
ejection 17 25 481 489 I-clinical_variable
fraction 26 34 490 498 I-clinical_variable
( 35 36 499 500 I-clinical_variable
LVEF 36 40 500 504 I-clinical_variable
) 40 41 504 505 I-clinical_variable
results 42 49 506 513 O
must 50 54 514 518 O
be 55 57 519 521 O
> 58 59 522 523 O
= 59 60 523 524 O
lower 61 66 525 530 B-clinical_variable
limit 67 72 531 536 I-clinical_variable
of 73 75 537 539 I-clinical_variable
normal 76 82 540 546 I-clinical_variable
( 83 84 547 548 I-clinical_variable
LLN 84 87 548 551 I-clinical_variable
) 87 88 551 552 I-clinical_variable
for 89 92 553 556 O
institution 93 104 557 568 O
performing 105 115 569 579 O
based 116 121 580 585 O
on 122 124 586 588 O
results 125 132 589 596 O
from 133 137 597 601 O
the 138 141 602 605 O
multi 142 147 606 611 O
- 147 148 611 612 O
gated 148 153 612 617 O
acquisition 154 165 618 629 O
( 166 167 630 631 O
MUGA 167 171 631 635 O
) 171 172 635 636 O
or 173 175 637 639 O
echocardiogram 176 190 640 654 B-treatment
( 191 192 655 656 I-treatment
ECHO 192 196 656 660 I-treatment
) 196 197 660 661 I-treatment
done 198 202 662 666 O
at 203 205 667 669 O
baseline 206 214 670 678 O

Lymphocyte 0 10 679 689 B-clinical_variable
count 11 16 690 695 I-clinical_variable
> 17 18 696 697 O
= 18 19 697 698 O
800 20 23 699 702 B-lower_bound
/ 23 24 702 703 I-lower_bound
mm^3 24 28 703 707 I-lower_bound

New 0 3 708 711 O
York 4 8 712 716 O
Heart 9 14 717 722 O
Association 15 26 723 734 O
functional 27 37 735 745 O
class 38 43 746 751 O
III 44 47 752 755 O
- 47 48 755 756 O
IV 48 50 756 758 O
heart 51 56 759 764 B-chronic_disease
failure 57 64 765 772 I-chronic_disease
on 65 67 773 775 O
active 68 74 776 782 B-treatment
treatment 75 84 783 792 I-treatment

Patients 0 8 793 801 O
must 9 13 802 806 O
be 14 16 807 809 O
at 17 19 810 812 O
least 20 25 813 818 O
28 26 28 819 821 B-lower_bound
days 29 33 822 826 I-lower_bound
post 34 38 827 831 B-treatment
cytotoxic 39 48 832 841 I-treatment
chemotherapy 49 61 842 854 I-treatment
, 61 62 854 855 O
radiotherapy 63 75 856 868 B-treatment
, 75 76 868 869 O
monoclonal 77 87 870 880 B-treatment
antibody 88 96 881 889 I-treatment
and/or 97 103 890 896 O
other 104 109 897 902 O
biologic 110 118 903 911 B-treatment
therapy 119 126 912 919 I-treatment
, 126 127 919 920 O
prior 128 133 921 926 O
to 134 136 927 929 O
enrollment 137 147 930 940 O

Patients 0 8 941 949 O
must 9 13 950 954 O
be 14 16 955 957 O
at 17 19 958 960 O
least 20 25 961 966 O
28 26 28 967 969 B-lower_bound
days 29 33 970 974 I-lower_bound
post 34 38 975 979 O
systemic 39 47 980 988 O
steroids 48 56 989 997 O
prior 57 62 998 1003 O
to 63 65 1004 1006 O
enrollment 66 76 1007 1017 O

Patients 0 8 1018 1026 O
must 9 13 1027 1031 O
have 14 18 1032 1036 O
Eastern 19 26 1037 1044 B-clinical_variable
Cooperative 27 38 1045 1056 I-clinical_variable
Oncology 39 47 1057 1065 I-clinical_variable
Group 48 53 1066 1071 I-clinical_variable
( 54 55 1072 1073 I-clinical_variable
ECOG 55 59 1073 1077 I-clinical_variable
) 59 60 1077 1078 I-clinical_variable
performance 61 72 1079 1090 I-clinical_variable
status 73 79 1091 1097 I-clinical_variable
score 80 85 1098 1103 I-clinical_variable
of 86 88 1104 1106 O
= 89 90 1107 1108 O
< 90 91 1108 1109 O
2 92 93 1110 1111 B-upper_bound

Patients 0 8 1112 1120 O
must 9 13 1121 1125 O
have 14 18 1126 1130 O
recovered 19 28 1131 1140 O
from 29 33 1141 1145 O
major 34 39 1146 1151 B-chronic_disease
infections 40 50 1152 1162 I-chronic_disease
and/or 51 57 1163 1169 O
surgical 58 66 1170 1178 B-treatment
procedures 67 77 1179 1189 I-treatment

Patients 0 8 1190 1198 O
who 9 12 1199 1202 O
are 13 16 1203 1206 O
having 17 23 1207 1213 O
sex 24 27 1214 1217 O
that 28 32 1218 1222 O
can 33 36 1223 1226 O
lead 37 41 1227 1231 O
to 42 44 1232 1234 O
pregnancy 45 54 1235 1244 B-pregnancy
must 55 59 1245 1249 O
agree 60 65 1250 1255 B-contraception_consent
to 66 68 1256 1258 I-contraception_consent
use 69 72 1259 1262 I-contraception_consent
adequate 73 81 1263 1271 I-contraception_consent
contraception 82 95 1272 1285 I-contraception_consent
( 96 97 1286 1287 I-contraception_consent
hormonal 97 105 1287 1295 I-contraception_consent
, 105 106 1295 1296 I-contraception_consent
barrier 107 114 1297 1304 I-contraception_consent
method 115 121 1305 1311 I-contraception_consent
of 122 124 1312 1314 I-contraception_consent
birth 125 130 1315 1320 I-contraception_consent
control 131 138 1321 1328 I-contraception_consent
, 138 139 1328 1329 I-contraception_consent
or 140 142 1330 1332 I-contraception_consent
abstinence 143 153 1333 1343 I-contraception_consent
) 153 154 1343 1344 I-contraception_consent
for 155 158 1345 1348 O
the 159 162 1349 1352 O
duration 163 171 1353 1361 O
of 172 174 1362 1364 O
study 175 180 1365 1370 O
participation 181 194 1371 1384 O

Patients 0 8 1385 1393 O
with 9 13 1394 1398 O
any 14 17 1399 1402 O
contraindication 18 34 1403 1419 O
or 35 37 1420 1422 O
known 38 43 1423 1428 O
hypersensitivity 44 60 1429 1445 O
to 61 63 1446 1448 O
receiving 64 73 1449 1458 O
sargramostatin 74 88 1459 1473 B-allergy_name
( 89 90 1474 1475 O
recombinant 90 101 1475 1486 B-allergy_name
human 102 107 1487 1492 I-allergy_name
granulocyte 108 119 1493 1504 I-allergy_name
macrophage 120 130 1505 1515 I-allergy_name
colony 131 137 1516 1522 I-allergy_name
stimulating 138 149 1523 1534 I-allergy_name
factor 150 156 1535 1541 I-allergy_name
[ 157 158 1542 1543 I-allergy_name
rhuGM 158 163 1543 1548 I-allergy_name
- 163 164 1548 1549 I-allergy_name
CSF 164 167 1549 1552 I-allergy_name
] 167 168 1552 1553 I-allergy_name
) 168 169 1553 1554 O
or 170 172 1555 1557 O
other 173 178 1558 1563 O
yeast 179 184 1564 1569 O
based 185 190 1570 1575 O
products 191 199 1576 1584 O

Patients 0 8 1585 1593 O
with 9 13 1594 1598 O
non 14 17 1599 1602 B-cancer
- 17 18 1602 1603 I-cancer
metastatic 18 28 1603 1613 I-cancer
, 28 29 1613 1614 O
node 30 34 1615 1619 B-cancer
positive 35 43 1620 1628 I-cancer
, 43 44 1628 1629 O
HER2 45 49 1630 1634 B-cancer
negative 50 58 1635 1643 I-cancer
breast 59 65 1644 1650 I-cancer
cancer 66 72 1651 1657 I-cancer
, 72 73 1657 1658 O
confirmed 74 83 1659 1668 O
by 84 86 1669 1671 O
pathology 87 96 1672 1681 O
report 97 103 1682 1688 O
, 103 104 1688 1689 O
who 105 108 1690 1693 O
are 109 112 1694 1697 O
in 113 115 1698 1700 O
remission 116 125 1701 1710 O
and 126 129 1711 1714 O
defined 130 137 1715 1722 O
as 138 140 1723 1725 O
having 141 147 1726 1732 O
no 148 150 1733 1735 O
evidence 151 159 1736 1744 O
of 160 162 1745 1747 O
disease 163 170 1748 1755 O
( 171 172 1756 1757 O
NED 172 175 1757 1760 O
) 175 176 1760 1761 O

Platelet 0 8 1762 1770 B-clinical_variable
count 9 14 1771 1776 I-clinical_variable
> 15 16 1777 1778 O
= 16 17 1778 1779 O
75,000 18 24 1780 1786 B-lower_bound
/ 24 25 1786 1787 I-lower_bound
mm^3 25 29 1787 1791 I-lower_bound

Pregnant 0 8 1792 1800 B-pregnancy
women 9 14 1801 1806 B-gender

Symptomatic 0 11 1807 1818 B-chronic_disease
restrictive 12 23 1819 1830 I-chronic_disease
cardiomyopathy 24 38 1831 1845 I-chronic_disease

Unstable 0 8 1846 1854 B-chronic_disease
angina 9 15 1855 1861 I-chronic_disease
within 16 22 1862 1868 O
4 23 24 1869 1870 B-upper_bound
months 25 31 1871 1877 I-upper_bound
prior 32 37 1878 1883 I-upper_bound
to 38 40 1884 1886 O
enrollment 41 51 1887 1897 O

Willing 0 7 1898 1905 O
to 8 10 1906 1908 O
not 11 14 1909 1912 O
undergo 15 22 1913 1920 O
any 23 26 1921 1924 O
elective 27 35 1925 1933 B-treatment
surgical 36 44 1934 1942 I-treatment
procedure 45 54 1943 1952 I-treatment
with 55 59 1953 1957 I-treatment
general 60 67 1958 1965 I-treatment
anesthesia 68 78 1966 1976 I-treatment
or 79 81 1977 1979 O
conscious 82 91 1980 1989 B-treatment
sedation 92 100 1990 1998 I-treatment
through 101 108 1999 2006 O
the 109 112 2007 2010 O
1 113 114 2011 2012 B-upper_bound
month 115 120 2013 2018 I-upper_bound
post 121 125 2019 2023 B-treatment
- 125 126 2023 2024 I-treatment
vaccination 126 137 2024 2035 I-treatment
visit 138 143 2036 2041 O

creatinine 0 10 2042 2052 B-clinical_variable
clearance 11 20 2053 2062 I-clinical_variable
> 21 22 2063 2064 O
60 23 25 2065 2067 B-lower_bound
ml 26 28 2068 2070 I-lower_bound
/ 28 29 2070 2071 I-lower_bound
min 29 32 2071 2074 I-lower_bound

patients 0 8 2075 2083 O
on 9 11 2084 2086 O
bisphosphonates 12 27 2087 2102 B-treatment
, 27 28 2102 2103 O
denosumab 29 38 2104 2113 B-treatment
, 38 39 2113 2114 O
and/or 40 46 2115 2121 O
endocrine 47 56 2122 2131 B-treatment
therapy 57 64 2132 2139 I-treatment
and 65 68 2140 2143 O
may 69 72 2144 2147 O
continue 73 81 2148 2156 O
throughout 82 92 2157 2167 O
duration 93 101 2168 2176 O
of 102 104 2177 2179 O
study 105 110 2180 2185 O

